RT @salvasapedraza: Chikatamarla, V.A. Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging. EJNMMI R…
RT @salvasapedraza: Chikatamarla, V.A. Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging. EJNMMI R…
RT @salvasapedraza: Metastatic disease according to [18F]PSMA-1007 PET/CT was associated with ISUP grade and PSA level. This is the largest…
RT @salvasapedraza: Chikatamarla, V.A. Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging. EJNMMI R…
Metastatic disease according to [18F]PSMA-1007 PET/CT was associated with ISUP grade and PSA level. This is the largest study using [18F]PSMA-1007 PET/CT to confirm a positive correlation of PSA level, ISUP grade and stage with primary prostate tumour SUVm
Chikatamarla, V.A. Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging. EJNMMI Res 11, 128 (2021). https://t.co/1K6jLWZcNW https://t.co/TtQJ1eHiLO
New article: Risk of metastatic disease using [(18)F]PSMA-1007 PET/CT for primary prostate cancer staging https://t.co/yfjZf9pJEV #prostatecancer #oncology https://t.co/axqclQtOmL